Announcement I June 4, 2018
RFA: CBC Catalyst Award
▸ CBC invites new applications
One-time incentive awards (up to $250,000), focused on basic biological/ biomedical research with transformative potential, made to teams with principals and other strong representation from at least two of the CBC institutions.
Application dates: August 20-24, 2018
Announcement I June 11, 2018
RFA: CBC Accelerator Award
▸ Announcing next round of applications
CBC Accelerator Award is a milestone-driven award program ($100,000 for 1st year) focused on translational research toward therapeutics or associated biomarkers and diagnostics.
Application dates: January 14-18, 2019
Announcement I June 22, 2018
CBC Accelerator Network (CBCAN)
▸ CBC Accelerator Award Program LOI Presentations
The next two CBCAN meetings will be dedicated to the LOI presentations by selected applicants for the CBC Accelerator Award Program, Round 2:
Part I: Thursday, August 2, 2018
Part II: Thursday, August 16, 2018
Announcement I April 23, 2018
16th Annual CBC Symposium
▸ A New Age of Structural Biology: Structure Meets Dynamics
Featuring: Jingyi FEI, UChicago; André HOELZ, Caltech; Janet SMITH, University of Michigan; Reza VAFABAKHSH, NU; Eric XU, Van Andel Institute and Xiaojing YANG, UIC.
Date: October 3, 2018
SUCCESS STORY I August 9, 2018
▸ Top-down Proteomics
Featuring CBC Senior Investigator—Neil Kelleher, NU
CBC Senior Investigator, Neil Kelleher, NU, explains the advantages of “top-down” versus “bottom-up” proteomics in early cancer detection and progression.
SUCCESS STORY I August 9, 2018
▸ Synthetic biology wins NIH support
Featuring CBC awardee—Josh Leonard, NU
CBC affiliate, Josh Leonard, NU, a co-PI on an NIH grant for a project in the interdisciplinary field of synthetic biology.
SUCCESS STORY I August 8, 2018
▸ Lisagor Award 2018
Featuring CBC awardee—Marcus Kronforst, UChicago
CBC affiliate and evolutionary biologist, Marcus Kronforst, UChicago, recognized with a Lisagor Award for his educational work on Chicago PBS series, ‘Urban Nature.’
▸ Changes in FDA’s Approach to Predictive Toxicology
By Jim Audia, CBC Executive Director
Safety assessment or predictive toxicology is a critical component of drug discovery. Understanding both the real and potential toxicities of novel therapeutic agents is necessary to guide the thoughtful clinical development. CBC has planned an educational workshop next Spring (2019) on “Preclinical Safety Assessment and Mitigation Strategies in Drug Discovery” to cover this important topic and provide some guidance for the successful filing of an Investigational New Drug (IND) application. This is far from a static landscape and the thinking about all aspects of predictive toxicology is changing within the Food and Drug Administration’s Toxicology Working Group.
▸ More posts
August 16-17, 2018
UIC Department of Molecular, Cell, and Developmental Biology
▸ A Collaborative Project Incubator for Quantitive Cell Biologists and Computational Modelers
August 29, 2018
NU Center for Molecular Innovation and Drug Discovery (CMIDD)
▸ The Chemical Impact on Life Sciences Colloquium & Scientific Poster Session
August 30, 2018
NU Postdoctoral Forum
▸ Current Research and Future Careers
▸ More events